Congressional leaders have urged the creation of federal guidelines to ensure the safe incorporation of psychedelic-assisted therapies into mainstream U.S. healthcare, emphasizing the need for a structured regulatory approach. The push comes as interest in these treatments grows, raising questions about oversight, patient safety, and clinical integration. Supporters argue that standardized protocols could bridge the gap between emerging research and medical practice, while critics warn of potential risks without proper safeguards. The proposal highlights a broader debate over how to balance innovation with regulation in mental health care.
Congressional leaders Jack Bergman and Lou Correa called for the establishment of national standards and a regulatory framework to safely integrate psychedelic-assisted therapies into the U.S. healthcare system.
